Monday, February 2, 2015

Dendreon (DNDN) has been acquired by Valeant Pharmaceuticals (VRX) (2/15)

Dendreon (DNDN) filed for Chapter 11 bankruptcy protection in November 2014. In February 2015, Valeant Pharmaceuticals (VRX) received approval to purchase all Dendreon assets.
        
Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)